摘要
目的探讨鼠神经生长因子(NGF)联合奥拉西坦治疗脑梗死对患者神经功能缺损程度的影响。方法以我院96例脑梗死患者为研究对象,随机分为两组,治疗14 d后,观察两组患者神经功能缺损评分(NIHSS)的变化,评价临床疗效。结果治疗14 d后,两组患者NIHSS评分降低,且观察组较对照组NIHSS评分更低,观察组治疗总有效率高于对照组(87.50%vs.66.67%),差异均具有统计学意义(P<0.05)。结论 NGF联合奥拉西坦治疗脑梗死能够改善患者神经功能缺损程度,且临床疗效确切。
Objective To observe the effect of mouse NGF combined with oxiracetam on neurological deficit in patients with cerebral infarction. Methods 96 patients were divided into observation group and control group. After 14 days of treatment, the NIHSS and the clinical efficacy were evaluated. Results The NIHSS score of observation group was significantly lower than control group, and the total effective rate was significantly higher than control group, the difference was statistically significant （P 〈 0.05）. Conclusion NGF combined with oxiracetam in the treatment of cerebral infarction can significantly improve the degree of neurological deficits in patients, the clinical efficacy is exact.
出处
《中国卫生标准管理》
2017年第20期84-85,共2页
China Health Standard Management
关键词
鼠神经生长因子
奥拉西坦
脑梗死
神经功能缺损
mouse nerve growth factor
oxiracetam
cerebral infarction
neurological deficit
